NextGen Healthcare, Inc. provided preliminary unaudited earnings guidance for the fourth quarter and full year ended March 31, 2022 and for the fiscal year 2023. For the fiscal 2022 fourth quarter, on a GAAP basis, preliminary unaudited revenue is expected to be between $150 and $152 million, compared to $144.2 million in the fourth quarter a year ago. Preliminary bookings for the fiscal 2022 fourth quarter is expected to achieve a quarterly record level of approximately $41 million. On a GAAP basis, preliminary unaudited fully diluted net income per share for the fiscal 2022 fourth quarter is expected to be between $0.00 and $0.02, compared to $0.01 net loss per share in the fourth quarter a year ago.

For the fiscal year 2022, on a GAAP basis, preliminary unaudited revenue is expected to be between $595 and $597 million, compared to $556.8 million in fiscal year 2021. Preliminary bookings for the fiscal year 2022 is expected to be approximately $152 million. On a GAAP basis, preliminary unaudited fully diluted net income per share for the fiscal year 2022 is expected to be between $0.01 and $0.03, compared to $0.14net income per share in the fiscal year 2021.

For the fiscal year 2023, the company expects revenue between $628 and $640 million.